Anthem Biosciences Ltd. - Research Center

---

Results

Statement

• Cash flow

More

Mar ' 25	Mar ' 24	Mar ' 22	Mar ' 21

Profit before tax

711.42

484.77

545.48

365.12

Net cashflow-operating activity

439.84

164.41

333.35

277.55

Net cash used in investing activity

-246.31

-191.76

-205.78

-196.09

Netcash used in fin. activity

-66.42

-131.59

180.68

-63.27

Net inc/dec in cash and equivlnt

127.10

-158.95

308.24

18.19

Cash and equivalnt begin of year

183.85

342.79

40.62

22.43

Cash and equivalnt end of year

310.95

183.85

348.87

40.62